Mankind Pharma Ltd.
NSE: MANKIND | BSE: 543904
₹2,364.10
₹7.90
(0.34%)
As on 17-Jun-2026IST
Market cap
₹97,612 Cr
Revenue (TTM)
₹14,278 Cr
P/E Ratio
51
P/B Ratio
6
Div. Yield
0 %
Quality Score
7/10
Growth Score
7/10
Valuation Score
4/10
Momentum Score
6/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹1,913 Cr
-
ROE
17 %
-
ROCE
18.3 %
-
Industry P/E
34.48
-
EV/EBITDA
26
-
Debt to Equity
0.2
-
Book Value
₹394.7
-
EPS
₹48.9
-
Face value
1
-
Shares outstanding
412,995,978
10 Years Aggregate
CFO
₹10,889.22 Cr
EBITDA
₹16,050.64 Cr
Net Profit
₹11,497.60 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Mankind Pharma
| 7.6 | -5.5 | 12.9 | -0.2 | 13.3 | -- | -- |
|
BSE Healthcare
| 8.3 | -0.3 | 11.2 | 6.5 | 23.4 | 13.3 | 12.1 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
Mankind Pharma
| -23.8 | 45.5 |
|
BSE Mid Cap
| 1.1 | 25.8 |
|
BSE Healthcare
| -3.3 | 43.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Mankind Pharma
|
2,364.1 | 97,611.6 | 14,277.6 | 1,926.4 | 19.1 | 12.8 | 51 | 6.0 |
| 25,955.0 | 55,143.7 | 6,929.1 | 1,552.0 | 26.2 | 35.3 | 35.5 | 11.6 | |
| 5,347.5 | 63,929.6 | 14,712.3 | 2,353.1 | 17.8 | 17.7 | 27.8 | 4.6 | |
| 1,422.4 | 81,824.5 | 33,653.1 | 3,501.5 | 14.9 | 9.7 | 23.3 | 2.2 | |
| 411.9 | 66,732.8 | 16,927.0 | 368.8 | 8.8 | -0.6 | 173.1 | 2.0 | |
| 2,199.8 | 37,249.9 | 3,821.7 | 1,036.0 | 32.5 | 48.8 | 36 | 16.3 | |
| 1,538.7 | 39,026.1 | 9,646.3 | 1,191.4 | 16.2 | 15.5 | 34.2 | 4.8 | |
| 2,272.0 | 1,03,645.5 | 27,958.0 | 5,355.5 | 26.6 | 27.4 | 19.4 | 4.6 | |
| 1,820.4 | 4,36,667.0 | 58,462.0 | 11,564.5 | 23.9 | 15.4 | 38 | 5.2 | |
| 1,061.4 | 1,06,811.7 | 27,148.4 | 5,026.4 | 21.9 | 20.7 | 21.2 | 3.9 |
Shareholding Pattern
View DetailsNews & Analysis
All News
About Mankind Pharma
Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of... anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. The company was incorporated in 1991 and is based in New Delhi, India. Read more
-
Incorporated
1991
-
Chairman
Ramesh Juneja
-
Managing Director
Rajeev Juneja
-
Headquarters
New Delhi, Delhi
-
Website
Looking for more details about Mankind Pharma Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Mankind Pharma
What is the current share price of Mankind Pharma Ltd Today?
The share price of Mankind Pharma Ltd is ₹2,364.10 (NSE) and ₹2,363.50 (BSE) as of 17-Jun-2026 IST. Mankind Pharma Ltd has given a return of 13.34% in the last 3 years.
What is the current PB & PE ratio of Mankind Pharma Ltd?
The P/E ratio of Mankind Pharma Ltd is 51.03 times as on 17-Jun-2026, a 48 premium to its peers’ median range of 34.48 times.
The P/B ratio of Mankind Pharma Ltd is 5.99 times as on 17-Jun-2026, a 23 premium to its peers’ median range of 4.88 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
50.22
|
7.00
|
|
2024
|
48.11
|
9.85
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Mankind Pharma Ltd?
The 52-week high and low of Mankind Pharma Ltd are Rs 2,716.50 and Rs 1,909.70 as of 17-Jun-2026.
What is the market cap of Mankind Pharma Ltd?
Mankind Pharma Ltd has a market capitalisation of ₹ 97,612 Cr as on 17-Jun-2026. As per SEBI classification, it is a Mid Cap company.
Should I invest in Mankind Pharma Ltd?
Before investing in Mankind Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.